The tweet was deleted by the author.
But we saved everything 🙂.
Enact has released its July training calendar, focusing on practical support for day-to-day work.
This month's sessions include loan scenario explainers, productivity tips, and instruction on ARMs and buydowns. The company invites participants to sign up using their NMLS ID.
The current price of ACT ($42.83) stands above the MA-20 ($42.20), MA-50 ($42.59), and well above the MA-200 ($39.99), confirming short- and medium-term bullish momentum as well as robust long-term support. The Ichimoku Kijun on D1 is at $42.36, which acts as immediate support; near-term support is clustered at $42.20–$42.36 (MA-20 and Ichimoku Kijun), with key support at $41.94 (MA-100), while the nearest resistance is at $42.59 (MA-50), followed by key resistance at $43.94 (MA-100).
Momentum on D1 is somewhat mixed: MACD indicates a strong sell, whereas ADX is neutral at low levels, pointing to a weak underlying trend. RSI sits at 51.12 with a buy bias, and Stoch RSI is flagged as overbought, while CCI remains neutral near 16. BBP shows overbought conditions (0.69), indicating buyers currently dominate intraday momentum with the price testing the top of the weekly range. AO is neutral. ACT is trading at $42.83, up from $42.41 a week ago, reflecting a 0.94% gain. The price is positioned at the very top of its weekly range, with weekly volatility amplitude at 2.36%, and the stock is showing upward consolidation near resistance.
Looking into next week, the expected trading range for ACT is $43.01–$43.35, which sits near its recent highs and well above the 52-week low of $33.94 but remains below this year's peak at $44.80. For the next five trading days, the probability of a continued price increase is very high (more than 80%), while a decline is seen as very unlikely. The baseline scenario anticipates sideways action within $43.01–$43.35. A bullish breakout above $43.35 could target the yearly high, while a bearish move below $43.01 may invite profit-taking but finds strong support above $42.20.
Previously it was reported that technical signals for Enact pointed to ongoing downside pressure and a low probability of near-term recovery. In light of current developments, investors should monitor whether the stock can establish support amid persistent volatility, as any break of key levels could set the tone for the next move.